Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003

被引:51
作者
Reinert, RR
Haupts, S
van der Linden, M
Heeg, C
Cil, MY
Al-Lahham, A
Fedson, DS
机构
[1] Univ Hosp RWTH Aachen, Natl Reference Ctr Streptococci, Inst Med Microbiol, D-5100 Aachen, Germany
[2] Univ Hosp RWTH Aachen, Natl Reference Ctr Streptococci, Inst Med Microbiol, Sergy Haut, France
关键词
clarithromycin; community-acquired pneumonia; penicillin G; resistance; serotypes; Streptococcus pneumoniae;
D O I
10.1111/j.1469-0691.2005.01282.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A population-based survey of invasive pneumococcal disease (IPD) was conducted among adults in North-Rhine Westphalia, Germany. The study included 202 of the 386 hospitals in the region, together with the 27 microbiological laboratories that submitted reports of IPD in these hospitals to the National Reference Centre for Streptococci. The reports of 16 laboratories were comprehensively reviewed. Most (95.8%) IPD isolates were susceptible to penicillin G, but 14.5% were resistant to clarithromycin. Serotypes 14 (15.6%), 3 (9.3%), 4 (7.1%) and 7F (7.9%) were the most common. The serotype coverage of the 23-valent pneumococcal polysaccharide vaccine was 80.8%. During 2001-2003, the annual incidence of IPD, after correcting for laboratory and hospital under-reporting, was 16.2/100 000 in individuals aged >= 65 years. In three university hospitals, blood cultures were obtained for only 37% of patients with community-acquired pneumonia, and fewer than one-third of such cultures were obtained in one hospital before antibiotics were prescribed, suggesting that the true incidence of IPD was closer to 50/100 000.
引用
收藏
页码:985 / 991
页数:7
相关论文
共 32 条
[1]   Cost-effectiveness of pneumococcal vaccination of older people:: A study in 5 western European countries [J].
Ament, A ;
Baltussen, R ;
Duru, G ;
Rigaud-Bully, C ;
de Graeve, D ;
Örtqvist, Å ;
Jönsson, B ;
Verhaegen, J ;
Gaillat, J ;
Christie, P ;
Cifre, AS ;
Vivas, D ;
Loiseau, C ;
Fedson, DS .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :444-450
[2]   Resistance among Streptococcus pneumoniae:: Implications for drug selection [J].
Appelbaum, PC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1613-1620
[3]   Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates [J].
Brueggemann, AB ;
Spratt, BG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :4966-4970
[4]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[5]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[6]   Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy [J].
D'Ancona, F ;
Salmaso, S ;
Barale, A ;
Boccia, D ;
Lopalco, PL ;
Rizzo, C ;
Monaco, M ;
Massari, M ;
Demicheli, V ;
Pantosti, A .
VACCINE, 2005, 23 (19) :2494-2500
[7]   Fluoroauinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain [J].
de la Campa, AG ;
Balsalobre, L ;
Ardanuy, C ;
Fenoll, A ;
Pérez-Trallero, E ;
Liñares, J .
EMERGING INFECTIOUS DISEASES, 2004, 10 (10) :1751-1759
[8]   Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults [J].
Fedson, DS ;
Liss, C .
VACCINE, 2004, 22 (08) :927-946
[9]  
FEDSON DS, 2004, VACCINES, P529
[10]   Historical changes in pneumococcal serogroup distribution: Implications for the era of pneumococcal conjugate vaccines [J].
Feikin, DR ;
Klugman, KP .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (05) :547-555